L’avis intitulé « Vaccin antigrippal FLUCELVAX : transition du vaccin antigrippal FLUCELVAX, de sa forme quadrivalente à une forme trivalente, dans la stratégie de vaccination contre la grippe saisonnière », ci-joint, est adopté.
Voir aussi
Recommandation vaccinale
13/02/2025
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
DTPr287nKFTj8Heq
